Why is waterborne pathogen risk rising in NHS estates?
The estate is ageing faster than it is being maintained. The cost of clearing the NHS estates maintenance backlog has risen around 20 percent to a record high, with clinicians warning that outdated buildings, including their water and air systems, are increasingly unable to cope.
The consequences show up quickly. In one recent case, an NHS maternity unit launched an infection-control investigation after discoloured hot water was found at several outlets, temporarily pausing neonatal external admissions and closing birthing pools while checks were carried out. Sector guidance has separately renewed the focus on managing Legionella and other waterborne pathogens across healthcare water systems, because the duty is personal and the consequences of a failure, in clinical and legal terms, are severe.
Who carries the duty, and what does a failure cost?
Water safety in a hospital is a named responsibility. The duty to control Legionella and waterborne pathogen risk sits with identified duty-holders under the relevant water-safety codes, and it is a duty to keep the risk under reliable, compliant control and to be able to prove it.
A failure is rarely just a remedial cost. It closes clinical services, as the maternity case shows, disrupts patient care, invites investigation, and carries reputational and legal exposure that outlasts the incident. For an infection-control or estates lead, the exposure is not theoretical, it is the standing risk that the next routine test comes back positive.
Why does conventional water treatment keep leaving the risk in place?
Most waterborne pathogens do not float freely where a dose of disinfectant can reach them. They live inside biofilm, a protective layer on the inside of pipes, tanks and outlets, where they are roughly a thousand times more resistant to conventional disinfectants than free-floating cells.
So a chlorine-based dose can clear what is in the water column and leave the reservoir in the biofilm untouched, and the contamination returns. That is why a system can pass one month and fail the next: the dosing treats the symptom in the water, not the biofilm that keeps reseeding it.
What does keeping NHS water demonstrably safe look like?
It means reframing the goal from dosing to control: going after the biofilm at source and proving the water is safe with independent evidence. Approaches that target biofilm directly are independently shown to remove 99.99 percent of it using a recognised standard method (ASTM E2799), which is the exact failure mode conventional dosing leaves behind.
- Risk: pathogen risk brought under reliable control, so incidents and the service closures that follow them are designed out.
- Obligation: the duty of care evidenced with independent laboratory results, ready for inspection and accreditation rather than asserted.
- Cost: less repeat dosing, and fewer emergency interventions, closures and re-tests, which are where the real money and disruption sit.
What does proven water safety look like in practice?
At a major UK airport, a recurring pathogen problem that had resisted conventional chemical treatment for years was cleared by targeting the biofilm, taking bioload from 600 to 0 cfu/g in four days, with all six test sites moving from fail to pass, verified by a UKAS-accredited laboratory, and then held on a routine maintenance dose.
At a private estate, 62.5 litres treated 1.6 million litres of water, clearing the biofilm and returning zero Legionella, E. coli and coliforms, verified by a water-authority laboratory. The pattern in both is the one an NHS duty-holder needs: the risk brought to zero, held there, and independently evidenced.
What should an estates or infection-control lead do first?
Start with a clear view of where your water systems stand today and where the biofilm risk is concentrated. A water-safety assessment identifies the outlets and assets most likely to fail, and sets out how to bring the risk under evidenced control, usually with less chemistry rather than more.